期刊文献+

不同浓度右美托咪啶对小儿麻醉后血清肌钙蛋白I、C反应蛋白以及补体水平的影响 被引量:3

Effect of Different Concentrations of Dexmedetomidine on the Serum CRP,Troponin I and Complement Levels of Children after Anesthesia
原文传递
导出
摘要 目的:探讨不同浓度右美托咪啶对小儿麻醉后血清肌钙蛋白I、C反应蛋白(CRP)及补体水平的影响。方法:选取我院收治的拟行手术的患儿60例,根据应用右美托咪定的浓度随机分为A、B、C三组,每组各20例。A、B组患儿予右美托咪啶0.5、0.25μg/kg的负荷剂量静脉推注给药10分钟,然后以0.2-0.7μg/kg/h的速度持续静脉微量泵入维持患者镇静状态,C组直接以右美托咪啶0.2-0.7μg/kg/h的速度持续泵入维持镇静状态。比较三组患儿麻醉术后的苏醒情况,麻醉前后不同时点血清肌钙蛋白I、C反应蛋白及补体水平的变化。结果:治疗前,三组患儿的各项指标比较均无统计学差异(P>0.05);治疗后,与A、C两组比较,B组患者自主呼吸恢复时间、气管导管拔管时间、解除监护时间显著缩短(P<0.05),术后24、72 h血清CRP水平更低,术后1、6、24 h血清肌钙蛋白I水平较低(P<0.05),术后1、24、72 h血清补体水平较高(P<0.05)。结论:0.25μg/kg浓度的右美托咪啶对于对小儿麻醉后血清肌钙蛋白I、C反应蛋白及补体水平的影响明显,且有助于患儿术后的苏醒。 Objective: To investigate the effects of different concentrations of dexmedetomidine on the serum CRP, troponin I and complement levels of children after anesthesia. Methods: 60 patients undergoing operation in our hospital were selected and randomly di- vided into three groups according to the application of different concentrations of dexmedetomidine, 20 cases in each group. Children in group A and B were given 0.5, 0.25 ixg/kg dexmedetomidine through intravenous injection for 10 min, and then were maintained by dexmedetomidine at 0.2-0.7 μg/kg/h through continuous intravenous trace pumping, while children in group C were given dexmedeto- midine at 0.2-0.7 μg/kg/h through continuous intravenous trace pumping alone. The analepsia time, serum CRP, troponin I and comple- ment levels of children at different time points before and after anesthesia were compared between three groups. Results: Before treat- ment, no significant difference was found in the different indicators between three groups (P〉0.05). After treatment, comprared with group A and group C, the spontaneous breathing recovery time, tracheal extubation time, lift the monitoring time of children in group B were all significantly shorter (P〈0.05), the seruna CRP levels at 24, 72 h after operation were significantly lower, the cardiac troponin I levels at 1, 6 24 h after operation were also significantly lower (P〈0.05), while the serum complement levels at 1, 24,72 h after operation were obviously higher(P〈0.05). Conclusions: 0.25 μg/kg dexmedetomidine had obvious effect on the serum cardiac troponin I, C reactive protein and complement levels of children after anesthesia, and could promote the analepsia of children.
出处 《现代生物医学进展》 CAS 2015年第29期5674-5677,共4页 Progress in Modern Biomedicine
基金 国家自然科学基金项目(30671989)
关键词 右美托咪啶 肌钙蛋白I C反应蛋白 补体 Dexmedetomidine Troponin I C-reactive protein Complement
  • 相关文献

参考文献20

  • 1Funai Y, Picketing AE, Uta D, et al. Systemic dexrnedetomidine aug- ments inhibitory synaptic transmission in the superficial dorsal horn through activation of descending noradrenergic control: an in vivo patch-clamp analysis of analgesic mechanisms[J]. Pain, 2014, 155(3): 617-628.
  • 2Iirola T, Aantaa R, Laltio R, et al. Pharmacokinetics of prolonged infu- sion of high-dose dexmedetomidine in critically ill patients [J]. Criti- cal Care, 2011, 15(5):R257.
  • 3Kosugi T, Mizuta K, Fujita T, et al.High concentrations of dexmedeto- midine inhibit compound action potentials in frog sciatic nerves with- out ct2 adrenoceptor activation [J]. British Journal of Pharmacology, 2010, 160(7):1662-1676.
  • 4Si Y, Bao H, I-Ian L, et al. Dexmedetomidine protects against renal is- chemia and reperfusion injury by inhibiting the JAK/STAT signaling activation[J]. Journal of Translational Medicine, 2013, 11(9): 141.
  • 5Su F, Nicolson SC, Zuppa AF. A Dose-Response Study of Dexmedetu- midine Administered as the Primary Sedative in Infants Following Open Heart Surgery [J]. Pediatric critical care medicine, 2013, 14(5): 499-507.
  • 6Pasin L, Crreco T, Feltracco P, et al. Dexmedetomidine as a Sedative Agent in Critically Ill Patients: A Meta-Analysis of Randomized Con- trolled Trials[J]. PLoS ONE, 2013, 8(12): e82913.
  • 7Li Y, Zeng M, Chen W, et al. Dexmedetomidine Reduces Isoflurane- Induced Neuroapoptosis Partly by Preserving PI3K/Akt Pathway in the Hippocampus of Neonatal Rats [J]. PLoS ONE, 2014, 9 (4): e93639.
  • 8Valitalo PA, Ahtola-Satila T, Wighton A, et al. Population Pharma- cokinetics of Dexmedetumidine in Critically IU Patients [J]. Clinical Drug Investigation, 2013, 33(8): 579-587.
  • 9Hayama Dmmhelle KM, Mastromonaco M, et al. Event-related Functional Magnetic Resonance Imaging of a Low Dose of Dexmede-tomidine that Impairs Long-term Memory [J]. Anesthesiology, 2012, 117(5): 981-995.
  • 10Jiang L, Li L, Shen J, et al. Effect of dexraedetomidine on lung is- chemia-reperfusion injury [J]. Molecular Medicine Reports, 2014, 9 (2): 419-426.

同被引文献36

引证文献3

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部